National Cancer Institute
Schedules
TAFS: 075-0849 /2023 - National Cancer Institute
| Line # | Split | Description | Iteration 1 Previously Approved Amount | Iteration 2 Current OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1100 | BA: Disc: Appropriation | $7,104,159,000 | $7,104,159,000 | ||
| 1120 | 1 | BA: Disc: Approps transferred to other accounts | Line added— | -$259,652,000 -$259,652,000 | |
| 1120 | BA: Disc: Approps transferred to other accounts | -$259,652,000 | +$259,652,000 Line removed— | ||
| 1120 | 2 | BA: Disc: Approps transferred to other accounts | Line added— | -$2,918,000 -$2,918,000 | See footnotes below |
| Footnotes for line 1120 (2) (Current): | B1: Reflects amount transferred pursuant to Section 213 of the Consolidated Appropriations Act, 2023 (P.L. 117-328) relating to the NIH HIV/AIDS transfer. | ||||
| 1121 | BA: Disc: Approps transferred from other accounts | $259,652,000 | $259,652,000 | ||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$2,918,000 | +$2,918,000 $0 | See footnotes below | |
| Footnotes for line 1151 (Previous): | B1: Reflects amount transferred pursuant to Section 213 of the Consolidated Appropriations Act, 2023 (P.L. 117-328) relating to the NIH HIV/AIDS transfer. | ||||
| 1700 | BA: Disc: Spending auth: Collected | Line added— | +$22,453,780 $22,453,780 | ||
| 1701 | BA: Disc: Spending auth: Chng uncoll pymts Fed src | Line added— | +$4,515,765 $4,515,765 | ||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $40,200,000 | +$3,030,455 $43,230,455 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $7,141,441,000 | +$30,000,000 $7,171,441,000 | See footnotes below | |
| Footnotes for line 1920 (Current): | B2: Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. | ||||
| 6001 | Category A -- 1st quarter | $2,267,379,264 | $2,267,379,264 | ||
| 6002 | Category A -- 2nd quarter | $1,810,000,000 | $1,810,000,000 | ||
| 6003 | Category A -- 3rd quarter | $1,534,000,000 | $1,534,000,000 | ||
| 6004 | Category A -- 4th quarter | $1,530,061,736 | +$30,000,000 $1,560,061,736 | ||
| 6190 | Total budgetary resources available | $7,141,441,000 | +$30,000,000 $7,171,441,000 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
| Footnotes for line 6190 (Current): | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] | ||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
| B1 | Reflects amount transferred pursuant to Section 213 of the Consolidated Appropriations Act, 2023 (P.L. 117-328) relating to the NIH HIV/AIDS transfer. |
| B2 | Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.] |
| B1 | Reflects amount transferred pursuant to Section 213 of the Consolidated Appropriations Act, 2023 (P.L. 117-328) relating to the NIH HIV/AIDS transfer. |
| B2 | Pursuant to Public Law 117-328, $5,000,000 shall be transferred to Health and Human Services (HHS) "Office of Inspector General"(OIG) |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.